These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 28513614)

  • 1. Recurrent somatic JAK-STAT pathway variants within a RUNX1-mutated pedigree.
    Tawana K; Wang J; Király PA; Kállay K; Benyó G; Zombori M; Csomor J; Al Seraihi A; Rio-Machin A; Matolcsy A; Chelala C; Cavenagh J; Fitzgibbon J; Bödör C
    Eur J Hum Genet; 2017 Aug; 25(8):1020-1024. PubMed ID: 28513614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of RUNX1-JAK2 in Human Induced Pluripotent Stem Cell-Derived Hematopoietic Cells Activates the JAK-STAT and MYC Pathways.
    Fortschegger K; Husa AM; Schinnerl D; Nebral K; Strehl S
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A new form of familial platelet disorder caused by germline mutations in RUNX1 in a pedigree].
    Guan J; Wang LL; Wang CY; Zhu XM; Shuai HZ; Yi X; Zou L; Yu D; Cheng H
    Zhonghua Nei Ke Za Zhi; 2023 Apr; 62(4):393-400. PubMed ID: 37032134
    [No Abstract]   [Full Text] [Related]  

  • 4. Mutational analysis of JAK2, CBL, RUNX1, and NPM1 genes in familial aggregation of hematological malignancies.
    Hamadou WS; Bourdon V; Gaildrat P; Besbes S; Fabre A; Youssef YB; Regaieg H; Laatiri MA; Eisinger F; Mari V; Gesta P; Dreyfus H; Bonadona V; Dugast C; Zattara H; Faivre L; Jemni SY; Noguchi T; Khélif A; Sobol H; Soua Z
    Ann Hematol; 2016 Jun; 95(7):1043-50. PubMed ID: 27106701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Familial leukemia due to germline RUNX1 mutations: lessons learned from two decades of research and unsolved problems].
    Osato M; Nambu A
    Rinsho Ketsueki; 2020; 61(6):687-696. PubMed ID: 32624544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Germline bi-allelic
    Arfeuille C; Vial Y; Cadenet M; Caye-Eude A; Fenneteau O; Neven Q; Bonnard AA; Pizzi S; Carpentieri G; Capri Y; Girardi K; Pedace L; Macchiaiolo M; Boudhar K; Khaled MB; Chahla WA; Lutun A; Fahd M; Drunat S; Flex E; Dalle JH; Strullu M; Locatelli F; Tartaglia M; Cavé H
    Haematologica; 2024 Aug; 109(8):2542-2554. PubMed ID: 37981895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Five new pedigrees with inherited RUNX1 mutations causing familial platelet disorder with propensity to myeloid malignancy.
    Owen CJ; Toze CL; Koochin A; Forrest DL; Smith CA; Stevens JM; Jackson SC; Poon MC; Sinclair GD; Leber B; Johnson PR; Macheta A; Yin JA; Barnett MJ; Lister TA; Fitzgibbon J
    Blood; 2008 Dec; 112(12):4639-45. PubMed ID: 18723428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal sequencing of RUNX1 familial platelet disorder: new insights into genetic mechanisms of transformation to myeloid malignancies.
    Duarte BKL; Yamaguti-Hayakawa GG; Medina SS; Siqueira LH; Snetsinger B; Costa FF; Rauh MJ; Ozelo MC
    Br J Haematol; 2019 Sep; 186(5):724-734. PubMed ID: 31124578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High frequency of RUNX1 biallelic alteration in acute myeloid leukemia secondary to familial platelet disorder.
    Preudhomme C; Renneville A; Bourdon V; Philippe N; Roche-Lestienne C; Boissel N; Dhedin N; André JM; Cornillet-Lefebvre P; Baruchel A; Mozziconacci MJ; Sobol H
    Blood; 2009 May; 113(22):5583-7. PubMed ID: 19357396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical phenotype of germline RUNX1 mutations in relation to the accompanying somatic variants and RUNX1 isoform expression.
    Cabrerizo Granados D; Barbosa I; Baliakas P; Hellström-Lindberg E; Lundin V
    Genes Chromosomes Cancer; 2023 Nov; 62(11):672-677. PubMed ID: 37303296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and molecular characterization of a novel 3′ mutation in RUNX1 in a family with familial platelet disorder.
    Churpek JE; Garcia JS; Madzo J; Jackson SA; Onel K; Godley LA
    Leuk Lymphoma; 2010 Oct; 51(10):1931-5. PubMed ID: 20846103
    [No Abstract]   [Full Text] [Related]  

  • 12. RUNX1-mutated families show phenotype heterogeneity and a somatic mutation profile unique to germline predisposed AML.
    Brown AL; Arts P; Carmichael CL; Babic M; Dobbins J; Chong CE; Schreiber AW; Feng J; Phillips K; Wang PPS; Ha T; Homan CC; King-Smith SL; Rawlings L; Vakulin C; Dubowsky A; Burdett J; Moore S; McKavanagh G; Henry D; Wells A; Mercorella B; Nicola M; Suttle J; Wilkins E; Li XC; Michaud J; Brautigan P; Cannon P; Altree M; Jaensch L; Fine M; Butcher C; D'Andrea RJ; Lewis ID; Hiwase DK; Papaemmanuil E; Horwitz MS; Natsoulis G; Rienhoff HY; Patton N; Mapp S; Susman R; Morgan S; Cooney J; Currie M; Popat U; Bochtler T; Izraeli S; Bradstock K; Godley LA; Krämer A; Fröhling S; Wei AH; Forsyth C; Mar Fan H; Poplawski NK; Hahn CN; Scott HS
    Blood Adv; 2020 Mar; 4(6):1131-1144. PubMed ID: 32208489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinctive phenotypes in two children with novel germline
    Bagla S; Regling KA; Wakeling EN; Gadgeel M; Buck S; Zaidi AU; Flore LA; Chicka M; Schiffer CA; Chitlur MB; Ravindranath Y
    Pediatr Hematol Oncol; 2021 Feb; 38(1):65-79. PubMed ID: 32990483
    [No Abstract]   [Full Text] [Related]  

  • 14. JAK2 inhibitors in the treatment of myeloproliferative neoplasms.
    Tibes R; Bogenberger JM; Geyer HL; Mesa RA
    Expert Opin Investig Drugs; 2012 Dec; 21(12):1755-74. PubMed ID: 22991927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Old Dog Has a New Trick: Somatic Exonic Deletions in RUNX1 Are Frequent in AML.
    Chakraborty J; Stengel KR
    Clin Cancer Res; 2023 Aug; 29(15):2742-2744. PubMed ID: 37289016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Janus kinase 2 variants associated with the transformation of myeloproliferative neoplasms into acute myeloid leukemia.
    Benton CB; Boddu PC; DiNardo CD; Bose P; Wang F; Assi R; Pemmaraju N; Kc D; Pierce S; Patel K; Konopleva M; Ravandi F; Garcia-Manero G; Kadia TM; Cortes J; Kantarjian HM; Andreeff M; Verstovsek S
    Cancer; 2019 Jun; 125(11):1855-1866. PubMed ID: 30811597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel pedigree with heterozygous germline RUNX1 mutation causing familial MDS-related AML: can these families serve as a multistep model for leukemic transformation?
    Ripperger T; Steinemann D; Göhring G; Finke J; Niemeyer CM; Strahm B; Schlegelberger B
    Leukemia; 2009 Jul; 23(7):1364-6. PubMed ID: 19387465
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of LNK/SH2B3 genetic alterations in myeloproliferative neoplasms and other hematological disorders.
    Maslah N; Cassinat B; Verger E; Kiladjian JJ; Velazquez L
    Leukemia; 2017 Aug; 31(8):1661-1670. PubMed ID: 28484264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatic mutational landscape of hereditary hematopoietic malignancies caused by germline variants in RUNX1, GATA2, and DDX41.
    Homan CC; Drazer MW; Yu K; Lawrence DM; Feng J; Arriola-Martinez L; Pozsgai MJ; McNeely KE; Ha T; Venugopal P; Arts P; King-Smith SL; Cheah J; Armstrong M; Wang P; Bödör C; Cantor AB; Cazzola M; Degelman E; DiNardo CD; Duployez N; Favier R; Fröhling S; Rio-Machin A; Klco JM; Krämer A; Kurokawa M; Lee J; Malcovati L; Morgan NV; Natsoulis G; Owen C; Patel KP; Preudhomme C; Raslova H; Rienhoff H; Ripperger T; Schulte R; Tawana K; Velloso E; Yan B; Kim E; Sood R; Hsu AP; Holland SM; Phillips K; Poplawski NK; Babic M; Wei AH; Forsyth C; Mar Fan H; Lewis ID; Cooney J; Susman R; Fox LC; Blombery P; Singhal D; Hiwase D; Phipson B; Schreiber AW; Hahn CN; Scott HS; Liu P; Godley LA; Brown AL;
    Blood Adv; 2023 Oct; 7(20):6092-6107. PubMed ID: 37406166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RUNX1 and CBFβ Mutations and Activities of Their Wild-Type Alleles in AML.
    Hyde RK; Liu P; Friedman AD
    Adv Exp Med Biol; 2017; 962():265-282. PubMed ID: 28299663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.